taselisib development code former cancer drug candidate development roche small molecule phosphoinositide inhibitor targeting isoform roche announced june would development taselislib following top line results phase iii sandpiper currently running clinical continued patients exhibiting benefit antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikitaselisib